| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.83▲ | 4.78▲ | 4.77▲ | 4.65▲ | 4.62▲ |
| MA10 | 4.80▲ | 4.76▲ | 4.71▲ | 4.57▲ | 4.06▲ |
| MA20 | 4.77▲ | 4.70▲ | 4.64▲ | 4.61▲ | 2.88▲ |
| MA50 | 4.72▲ | 4.58▲ | 4.60▲ | 4.09▲ | 1.84▲ |
| MA100 | 4.65▲ | 4.61▲ | 4.65▲ | 2.76▲ | 1.60▲ |
| MA200 | 4.58▲ | 4.65▲ | 4.29▲ | 1.97▲ | 6.21▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.009▲ | 0.013▲ | 0.028▲ | -0.028▼ | 0.194▲ |
| RSI | 76.386▲ | 70.102▲ | 66.099▲ | 61.978▲ | 71.179▲ |
| STOCH | 94.841▲ | 67.551 | 74.847 | 63.700 | 61.761 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -22.764▲ | -34.178 |
| CCI | 169.435▲ | 195.588▲ | 157.121▲ | 72.465 | 73.459 |
| MA | $ANTX Price Crossed Above MA(13) | Set Alert |
|
Thursday, May 21, 2026 03:00 AM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, ...
|
|
Sunday, March 08, 2026 08:02 PM
If MASH becomes a routinely managed chronic disease-similar to diabetes or obesity-the healthcare system will require diagnostic tools capable of handling dramatically higher patient volumes. ENDRA's ...
|
|
Monday, January 12, 2026 07:16 AM
(RTTNews) - AN2 Therapeutics Inc. (ANTX) announced that the U.S. FDA has cleared its investigator-initiated trial evaluating Epetraborole in 90 patients with Mycobacterium abscessus lung disease, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/05/26 | 4.60 | 4.92 | 4.45 | 4.89 | 102,358 |
| 20/05/26 | 4.49 | 4.67 | 4.44 | 4.59 | 68,672 |
| 19/05/26 | 4.51 | 4.68 | 4.31 | 4.55 | 83,628 |
| 18/05/26 | 4.75 | 4.91 | 4.27 | 4.48 | 134,179 |
| 15/05/26 | 4.70 | 4.95 | 4.50 | 4.75 | 408,710 |
| 14/05/26 | 4.64 | 5.00 | 4.58 | 4.64 | 295,945 |
| 13/05/26 | 4.27 | 4.63 | 3.94 | 4.31 | 263,434 |
| 12/05/26 | 4.58 | 4.90 | 4.22 | 4.27 | 189,026 |
| 11/05/26 | 4.48 | 4.80 | 4.4601 | 4.72 | 213,688 |
| 08/05/26 | 4.59 | 4.83 | 4.46 | 4.46 | 241,951 |
|
|
||||
|
|
||||
|
|